Abstract
EVALUATION OF TREATMENT IN ADULT PATIENT WITH HODGKIN LYMPHOMAS, (LOW RISK, INTERMEDIATE AND HIGH RISK GROUPS), TREATED AT RADIATION AND ISOTOPES CENTRE OF KHARTOUM (RICK)

Eldirdiri M. Abdel Rahman, Enaam Abdel Rahman Abdel Gadir, Salma Awad Elkareem Ali, Sana E. Abdalla

ABSTRACT

Background: Hodgkin’s lymphoma is considered as a curable cancer. Since its discovery, continuous progress was achieved, in diagnosis and management. The aim of this study is to management compare complete remission in chemotherapy to combined management modality in each group, and in all patients. Methods: This study was performed among 84 Hodgkin’s including all groups, low risk, intermediate and high risk group lymphoma patients, in the age of ≥18 years who received treatment at radiation and isotope centre of Khartoum from year 2013-2016. Data was collecting usinh a well structured questionnaire from: Medical records, direct interview of patients and interview of responsible personnel. Analysis of data was done by Statistic Package For social Séance program version 19. Results: Comparison of chemotherapy to combined management treatment in the low risk group (favorable & unfavorable) and in high risk group showed no significant difference between two treatment modalities, also comparison between two treatment modalities in all patients revealed no significance difference. Conclusion: There was no significance difference between the chemotherapy and combined treatment modality in low, intermediate and high risk groups.

Keywords: Hodgkin Lymphoma, Chemotherapy, Radiotherapy.


[Full Text Article]   [Download Certificate]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: JUNE ISSUE PUBLISHED

    JUNE 2024 Issue has been successfully launched on 1 JUNE 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT